Net Income (Loss) Attributable to Parent in USD of Bionik Laboratories Corp. from Q3 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bionik Laboratories Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2010 to Q1 2023.
  • Bionik Laboratories Corp. Net Income (Loss) Attributable to Parent for the quarter ending 31 Mar 2023 was -$1,356,291.000, a 20.5% increase year-over-year.
  • Bionik Laboratories Corp. Net Income (Loss) Attributable to Parent for the twelve months ending 31 Mar 2023 was -$4,946,024.000, a 52.5% increase year-over-year.
  • Bionik Laboratories Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$4,946,024.000, a 52.5% increase from 2021.
  • Bionik Laboratories Corp. annual Net Income (Loss) Attributable to Parent for 2021 was -$10,407,994.000, a 23.6% increase from 2020.
  • Bionik Laboratories Corp. annual Net Income (Loss) Attributable to Parent for 2020 was -$13,620,457.000, a 45.6% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Bionik Laboratories Corp. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$4,946,024 -$1,356,291 +$348,957 +20.5% 01 Jan 2023 31 Mar 2023 10-K 21 Jun 2023
Q4 2022 -$5,294,981 -$1,076,211 +$5,907,634 +84.6% 01 Oct 2022 31 Dec 2022 10-Q 08 Feb 2023
Q3 2022 -$11,202,615 -$1,129,388 +$138,601 +10.9% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 -$11,341,216 -$1,384,134 -$933,222 -2.1% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2022
Q1 2022 -$10,407,994 -$1,705,248 -$670,370 -64.8% 01 Jan 2022 31 Mar 2022 10-K 21 Jun 2023
Q4 2021 -$9,737,624 -$6,983,845 +$1,967,036 +22% 01 Oct 2021 31 Dec 2021 10-Q 08 Feb 2023
Q3 2021 -$11,704,660 -$1,267,989 +$359,633 +22.1% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$12,064,293 -$450,912 +$1,556,164 +77.5% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 -$13,620,457 -$1,034,878 01 Jan 2021 31 Mar 2021 10-K 09 Jun 2022
Q4 2020 -$8,950,881 -$5,980,932 -2% 01 Oct 2020 31 Dec 2020 10-Q 09 Feb 2022
Q3 2020 -$1,627,622 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$2,007,076 +$113,568 +5.4% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q4 2019 -$2,969,949 01 Oct 2019 31 Dec 2019 10-Q 11 Feb 2021
Q2 2019 -$2,120,644 -$1,359,946 -1.8% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 -$3,428,635 -$9,617,789 -1.6% 01 Jan 2019 31 Mar 2019 10-Q 14 Feb 2020
Q2 2018 -$760,698 +$1,479,820 +66% 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019
Q1 2018 $6,189,154 01 Jan 2018 31 Mar 2018 10-Q 11 Feb 2019
Q2 2017 -$2,240,518 +$82,254 +3.5% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q2 2016 $214,994 -$2,322,772 -$821,154 -54.7% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 $1,036,148 -$1,004,092 +$6,630,054 +86.8% 01 Jan 2016 31 Mar 2016 10-Q 14 Feb 2017
Q4 2015 -$5,593,906 $1,223,100 +$1,843,131 01 Oct 2015 31 Dec 2015 10-KT 30 Jun 2016
Q3 2015 -$7,437,037 $2,318,758 +$3,492,013 01 Jul 2015 30 Sep 2015 10-Q 17 Mar 2016
Q2 2015 -$10,929,050 -$1,501,618 -$874,045 -1.4% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$10,055,005 -$7,634,146 -$7,551,665 -91.6% 01 Jan 2015 31 Mar 2015 10-KT 30 Jun 2016
Q4 2014 -$2,503,340 -$620,031 -$617,399 -234.6% 01 Oct 2014 31 Dec 2014 10-Q 17 Mar 2016
Q3 2014 -$1,885,941 -$1,173,255 -$1,171,480 01 Jul 2014 30 Sep 2014 10-Q 17 Mar 2016
Q2 2014 -$714,461 -$627,573 -$621,753 -106.8% 01 Apr 2014 30 Jun 2014 10-Q 17 Mar 2016
Q1 2014 -$92,708 -$82,481 -$79,599 -27.6% 01 Jan 2014 31 Mar 2014 10-Q 17 Mar 2016
Q4 2013 -$13,109 -$2,632 +$1,059,544 +99.8% 01 Oct 2013 31 Dec 2013 10-K 15 Apr 2015
Q3 2013 -$1,072,653 -$1,775* -$1,052,775 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 -$19,878 -$5,820 -$9,531 -2.6% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$10,347 -$2,882 -$960 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 -$9,387 -$1,062,176 01 Oct 2012 31 Dec 2012 10-K 15 Apr 2014
Q3 2012 $1,051,000 -$239,000 -18.5% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 $3,711 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 -$1,922* +$1,198,078 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q3 2011 $1,290,000 +$1,294,629 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012
Q1 2011 -$1,200,000 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q3 2010 -$4,629 01 Jul 2010 30 Sep 2010 10-Q 21 Nov 2011

Bionik Laboratories Corp. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$4,946,024 +$5,461,970 +52.5% 01 Apr 2022 31 Mar 2023 10-K 21 Jun 2023
2021 -$10,407,994 +$3,212,463 +23.6% 01 Apr 2021 31 Mar 2022 10-K 21 Jun 2023
2020 -$13,620,457 +$11,396,040 +45.6% 01 Apr 2020 31 Mar 2021 10-K 09 Jun 2022
2019 -$25,016,497 -$14,459,896 -1.4% 01 Apr 2019 31 Mar 2020 10-K 24 Jun 2021
2018 -$10,556,601 -$25,182,391 -1.7% 01 Apr 2018 31 Mar 2019 10-K 29 Jun 2020
2017 $14,625,790 +$22,695,192 01 Apr 2017 31 Mar 2018 10-K 01 Jul 2019
2016 -$8,069,402 -$2,475,496 -44.3% 01 Apr 2016 31 Mar 2017 10-K 27 Jun 2018
2015 -$5,593,906 -$5,564,378 -188.4% 01 Jan 2015 31 Dec 2015 10-KT 30 Jun 2016
2014 -$29,528 -$16,419 -1.3% 01 Jan 2014 31 Dec 2014 10-K 15 Apr 2015
2013 -$13,109 -$3,722 -39.7% 01 Jan 2013 31 Dec 2013 10-K 15 Apr 2015
2012 -$9,387 -$4,726 -1% 01 Jan 2012 31 Dec 2012 10-K 15 Apr 2014
2011 -$4,661 +$3,205 +40.7% 01 Jan 2011 31 Dec 2011 10-K 06 Mar 2013
2010 -$7,866 08 Jan 2010 31 Dec 2010 10-K 11 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.